Shoichi Fukui

2.2k total citations
86 papers, 1.3k citations indexed

About

Shoichi Fukui is a scholar working on Immunology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shoichi Fukui has authored 86 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 30 papers in Rheumatology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shoichi Fukui's work include Vasculitis and related conditions (19 papers), Systemic Lupus Erythematosus Research (10 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Shoichi Fukui is often cited by papers focused on Vasculitis and related conditions (19 papers), Systemic Lupus Erythematosus Research (10 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Shoichi Fukui collaborates with scholars based in Japan, United States and Germany. Shoichi Fukui's co-authors include Atsushi Kawakami, Shin‐ya Kawashiri, Mami Tamai, Naoki Iwamoto, Tomohiro Koga, Hideki Nakamura, Tomoki Origuchi, Kunihiro Ichinose, Masataka Umeda and Ayako Nishino and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Shoichi Fukui

83 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoichi Fukui Japan 19 557 394 386 216 149 86 1.3k
Cécile Contin‐Bordes France 19 619 1.1× 228 0.6× 306 0.8× 173 0.8× 118 0.8× 54 1.3k
Marcella Prete Italy 23 479 0.9× 421 1.1× 365 0.9× 205 0.9× 228 1.5× 68 1.6k
Taichi Hayashi Japan 23 735 1.3× 697 1.8× 275 0.7× 264 1.2× 170 1.1× 95 1.8k
Yasumori Izumi Japan 18 424 0.8× 358 0.9× 333 0.9× 177 0.8× 103 0.7× 88 1.1k
Yoshiro Horai Japan 18 326 0.6× 476 1.2× 189 0.5× 137 0.6× 121 0.8× 89 1.0k
Keiko Yoshimoto Japan 24 946 1.7× 555 1.4× 272 0.7× 198 0.9× 169 1.1× 84 1.7k
Francesca Wanda Rossi Italy 25 779 1.4× 313 0.8× 446 1.2× 238 1.1× 90 0.6× 82 1.8k
Nathalie Satta Switzerland 20 562 1.0× 239 0.6× 405 1.0× 93 0.4× 110 0.7× 36 1.3k
Toshimasa Shimizu Japan 17 321 0.6× 390 1.0× 249 0.6× 101 0.5× 134 0.9× 90 983
G. Szegedi Hungary 25 711 1.3× 923 2.3× 262 0.7× 208 1.0× 259 1.7× 79 1.9k

Countries citing papers authored by Shoichi Fukui

Since Specialization
Citations

This map shows the geographic impact of Shoichi Fukui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoichi Fukui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoichi Fukui more than expected).

Fields of papers citing papers by Shoichi Fukui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoichi Fukui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoichi Fukui. The network helps show where Shoichi Fukui may publish in the future.

Co-authorship network of co-authors of Shoichi Fukui

This figure shows the co-authorship network connecting the top 25 collaborators of Shoichi Fukui. A scholar is included among the top collaborators of Shoichi Fukui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoichi Fukui. Shoichi Fukui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fukui, Shoichi, Remi Sumiyoshi, Tomohiro Koga, et al.. (2025). A Phase Ib Investigator-Initiated Trial of Filgotinib in Patients With Idiopathic Multicentric Castleman Disease. Cureus. 17(2). e78865–e78865.
2.
Fukui, Shoichi, et al.. (2024). Improved Hearing Impairment of Granulomatosis with Polyangiitis Treated with Rituximab and Avacopan without Glucocorticoids. Internal Medicine. 63(17). 2455–2460. 5 indexed citations
3.
Fukui, Shoichi, et al.. (2023). Inhibition of protein arginine deiminase 4 prevents inflammation-mediated heart failure in arthritis. Life Science Alliance. 6(10). e202302055–e202302055. 7 indexed citations
4.
Iwamoto, Naoki, Shoichi Fukui, Shimpei Morimoto, et al.. (2023). Comparison of risks of cancer, infection, and MACEs associated with JAK inhibitor and TNF inhibitor treatment: a multicentre cohort study. Lara D. Veeken. 62(10). 3358–3365. 23 indexed citations
5.
Sumiyoshi, Remi, Tomohiro Koga, Shoichi Fukui, et al.. (2023). Exploring the role of insulin-like growth factor binding protein-1 in identifying idiopathic multicentric Castleman's disease types: Implications for the mTOR signaling pathway. Clinical Immunology. 256. 109798–109798. 2 indexed citations
6.
Fukui, Shoichi, et al.. (2022). NLRP3 inflammasome activation in neutrophils directs early inflammatory response in murine peritonitis. Scientific Reports. 12(1). 21313–21313. 10 indexed citations
7.
Fukui, Shoichi, et al.. (2022). Anti‐inflammatory protective effect of ADAMTS‐13 in murine arthritis models. Journal of Thrombosis and Haemostasis. 20(10). 2386–2393. 9 indexed citations
8.
Aymonnier, Karen, Julie Ng, Laura E. Fredenburgh, et al.. (2022). Inflammasome activation in neutrophils of patients with severe COVID-19. Blood Advances. 6(7). 2001–2013. 63 indexed citations
9.
10.
Koga, Tomohiro, Masataka Umeda, Nobuya Yoshida, et al.. (2022). Inhibition of calcium/calmodulin-dependent protein kinase IV in arthritis: dual effect on Th17 cell activation and osteoclastogenesis. Lara D. Veeken. 62(2). 861–871. 5 indexed citations
11.
Endo, Yushiro, Shoichi Fukui, Tomohiro Koga, et al.. (2021). Tocilizumab has no direct effect on cell lines infected with human T-cell leukemia virus type 1. Journal of International Medical Research. 49(3). 3619063011–3619063011. 2 indexed citations
12.
Matsumoto, Haruki, Yuya Fujita, Naoki Matsuoka, et al.. (2021). Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD). Arthritis Research & Therapy. 23(1). 148–148. 9 indexed citations
13.
Fukui, Shoichi, Shimpei Morimoto, Kunihiro Ichinose, et al.. (2020). Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis. Scientific Reports. 10(1). 9466–9466. 7 indexed citations
14.
Kawashiri, Shin‐ya, Keita Fujikawa, Ayako Nishino, et al.. (2019). Combination of ultrasound power Doppler‐verified synovitis and seropositivity accurately identifies patients with early‐stage rheumatoid arthritis. International Journal of Rheumatic Diseases. 22(5). 842–851. 5 indexed citations
15.
Shimizu, Yūji, Hirotomo Yamanashi, Yuko Noguchi, et al.. (2019). Short stature-related single-nucleotide polymorphism (SNP) activates endothelial repair activity in elderly Japanese. Environmental Health and Preventive Medicine. 24(1). 26–26. 7 indexed citations
16.
Kawashiri, Shin‐ya, Tomoki Origuchi, Masataka Umeda, et al.. (2018). Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease. Arthritis Research & Therapy. 20(1). 277–277. 14 indexed citations
17.
Fukui, Shoichi, Hideki Nakamura, Naoki Iwamoto, et al.. (2017). Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy. BMC Immunology. 18(1). 7–7. 13 indexed citations
18.
Fukui, Shoichi, Naoki Iwamoto, & Atsushi Kawakami. (2017). Drug-induced large vessel vasculitis with carotid arterial ring sign. Scandinavian Journal of Rheumatology. 47(1). 83–84. 8 indexed citations
19.
Fukui, Shoichi, Naoki Iwamoto, Masataka Umeda, et al.. (2016). Antineutrophilic cytoplasmic antibody-associated vasculitis with hypocomplementemia has a higher incidence of serious organ damage and a poor prognosis. Medicine. 95(37). e4871–e4871. 35 indexed citations
20.
Fukui, Shoichi, Naoki Iwamoto, Masataka Umeda, et al.. (2015). Eosinophilic Granulomatosis With Polyangiitis With Thrombotic Microangiopathy. Medicine. 94(45). e1943–e1943. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cécile Contin‐Bordes Breakdown of academic impact, for papers by Marcella Prete Breakdown of academic impact, for papers by Taichi Hayashi Breakdown of academic impact, for papers by Yasumori Izumi Breakdown of academic impact, for papers by Yoshiro Horai Breakdown of academic impact, for papers by Keiko Yoshimoto Breakdown of academic impact, for papers by Francesca Wanda Rossi Breakdown of academic impact, for papers by Nathalie Satta Breakdown of academic impact, for papers by Toshimasa Shimizu Breakdown of academic impact, for papers by G. Szegedi
Rankless by CCL
2026